Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Lung Inflammation
Interventions
DRUG

Zileuton

600 mg tablets po QID for 5 days prior to endotoxin, stopping 24 hours after endotoxin instillation

DRUG

Pioglitazone placebo

Lactose filled gelatin capsule, size 00, 1 tablet po bid x 2 weeks prior to endotoxin instillation until 24 hours after endotoxin.

DRUG

Zileuton placebo

Placebo tablets provided by manufacturer of Zyflo CR (Cornerstone Therapeutics), 2 tablets po bid x 5 days prior to endotoxin instillation until 24 hours after endotoxin.

DRUG

Pioglitazone

PPAR-gamma agonist

Trial Locations (1)

63110

Washington University / Barnes Jewish Hospital, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

collaborator

Doris Duke Charitable Foundation

OTHER

NCT01174056 - Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging | Biotech Hunter | Biotech Hunter